Insight Molecular Diagnostics
IMDX | NASDAQ
$1.86
-$0.28 (-13.08%)
At close: Nov 16, 2026, 4:00 PM ET
$1.53
-$0.33 (-17.74%)
After-hours:
Nov 16, 2026, 7:55 PM ET
Insight Molecular Diagnostics Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net OutflowTotal Institutions
41
Total Ownership
50.24%
Capital Flow
-$46.82M
Shares Change
-473.68K
Ownership Distribution
Institutions (50.24%)
Others (49.76%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
13
Increased Positions
23
Reduced Positions
8
Closed Positions
13
New (13)
Increased (23)
Reduced (8)
Closed (13)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 0.03% 0.00% | < 0.01% | 12.25K | 45.45K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Broadwood Capital Inc | 34.52% -0.14% | 3.91% +41.81% | 12.68M +6.31% | 74.84M +91.23% | |
| Awm Investment Company, Inc. | 7.72% -5.05% | 1.45% +42.55% | 2.84M +1.08% | 16.74M +81.83% | |
| Vanguard Capital Management LLC | 2.00% +28.67% | < 0.01% +112.86% | 735.85K +36.99% | 4.34M +146.41% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove IMDX